For years, scientists have held out hope that the rapidly evolving field of genetics could transform medical diagnosis and treatment, moving beyond a trial-and-error approach.
But the vision of individualized treatment based on a patient’s genetic makeup and other biological markers has yet to materialize, even if better use of genetic information has led to advances in cancer care and other areas.
Now the pursuit of “personalized medicine” is expected to get a major push from the incoming administration of president-elect Barack Obama. As a senator, Obama introduced legislation to coordinate the sometimes conflicting policies of government agencies and provide more support for private research. He remains keen on the idea.
“The president-elect has indicated his support for both advancing personalized medicine and increasing [research] funding,” said Representative Patrick Kennedy, who has introduced legislation in the House that builds on Obama’s.
Obama is also interested in the role that personalized medicine could play as an element of changes in the broader health care system.
“The issue of getting the right treatment to the right person goes with his whole emphasis on health reform,” said Mark McClellan, a noted Republican health care expert who served US President George W. Bush as Medicare director and head of the Food and Drug Administration (FDA).
“If we’re thinking about reforming the health care system, we should be thinking about what medicine will be like down the road when health care reform is fully implemented,” McClellan said.
Although medical science is more technologically advanced than at any time in history, in some ways it is still strikingly old-fashioned. For example, most prescription drugs are effective only in about 60 percent of treated patients, leading to a trial-and-error approach to treatment that not only may be more costly, but can put some patients at risk.
Among patients, the varying responses to medications may be linked to differences in genetic makeup that affect how the body processes a drug. For example, the Food and Drug Administration recently warned that certain drugs for epilepsy may prompt a severe skin reaction in Asian patients because of a genetic trait.
The practice of medicine could be streamlined if doctors had reliable ways of predicting which drugs would work on which individuals.
Government funding for research helped make possible many of the scientific gains in genetics, and Congress has passed landmark legislation outlawing discrimination against patients on the basis of genetic information.
But the mundane decisions, such as whether or not to pay for some genetic tests, have not progressed that smoothly.
For example, the FDA supported research that found certain genes can make some patients taking the blood thinner Coumadin susceptible to potentially fatal bleeding. The agency has been pushing for some time to make doctors aware of genetic tests that could help their patients.
But the government health program has not yet set a national policy on paying for the tests. Problems with Coumadin, also known as warfarin, are a major cause of emergency room visits for seniors.
“It would be very helpful if you could get [Medicare] and FDA talking to each other,” said Edward Abrahams, executive director of the Personalized Medicine Coalition.
“Right now they really don’t communicate very well, and they have different agendas. The federal government is not coordinated around removing the barriers to personalized medicine,” he said.
His group represents university research centers, industry and patients.
Obama’s legislation would create an interagency group to coordinate the policies of federal agencies whose decisions have an impact on the issue. Kennedy also would direct Medicare to set a fixed policy for coverage of genetic tests and treatments.
Nauru has started selling passports to fund climate action, but is so far struggling to attract new citizens to the low-lying, largely barren island in the Pacific Ocean. Nauru, one of the world’s smallest nations, has a novel plan to fund its fight against climate change by selling so-called “Golden Passports.” Selling for US$105,000 each, Nauru plans to drum up more than US$5 million in the first year of the “climate resilience citizenship” program. Almost six months after the scheme opened in February, Nauru has so far approved just six applications — covering two families and four individuals. Despite the slow start —
YELLOW SHIRTS: Many protesters were associated with pro-royalist groups that had previously supported the ouster of Paetongtarn’s father, Thaksin, in 2006 Protesters rallied on Saturday in the Thai capital to demand the resignation of court-suspended Thai Prime Minister Paetongtarn Shinawatra and in support of the armed forces following a violent border dispute with Cambodia that killed more than three dozen people and displaced more than 260,000. Gathered at Bangkok’s Victory Monument despite soaring temperatures, many sang patriotic songs and listened to speeches denouncing Paetongtarn and her father, former Thai prime minister Thaksin Shinawatra, and voiced their backing of the country’s army, which has always retained substantial power in the Southeast Asian country. Police said there were about 2,000 protesters by mid-afternoon, although
MOGAMI-CLASS FRIGATES: The deal is a ‘big step toward elevating national security cooperation with Australia, which is our special strategic partner,’ a Japanese official said Australia is to upgrade its navy with 11 Mogami-class frigates built by Japan’s Mitsubishi Heavy Industries, Australian Minister for Defence Richard Marles said yesterday. Billed as Japan’s biggest defense export deal since World War II, Australia is to pay US$6 billion over the next 10 years to acquire the fleet of stealth frigates. Australia is in the midst of a major military restructure, bolstering its navy with long-range firepower in an effort to deter China. It is striving to expand its fleet of major warships from 11 to 26 over the next decade. “This is clearly the biggest defense-industry agreement that has ever
DEADLY TASTE TEST: Erin Patterson tried to kill her estranged husband three times, police said in one of the major claims not heard during her initial trial Australia’s recently convicted mushroom murderer also tried to poison her husband with bolognese pasta and chicken korma curry, according to testimony aired yesterday after a suppression order lapsed. Home cook Erin Patterson was found guilty last month of murdering her husband’s parents and elderly aunt in 2023, lacing their beef Wellington lunch with lethal death cap mushrooms. A series of potentially damning allegations about Patterson’s behavior in the lead-up to the meal were withheld from the jury to give the mother-of-two a fair trial. Supreme Court Justice Christopher Beale yesterday rejected an application to keep these allegations secret. Patterson tried to kill her